Matches in Wikidata for { <http://www.wikidata.org/entity/Q81561771> ?p ?o ?g. }
Showing items 1 to 41 of
41
with 100 items per page.
- Q81561771 description "article scientifique publié en 2005" @default.
- Q81561771 description "artículu científicu espublizáu en xineru de 2005" @default.
- Q81561771 description "im Januar 2005 veröffentlichter wissenschaftlicher Artikel" @default.
- Q81561771 description "scientific article published on 13 January 2005" @default.
- Q81561771 description "wetenschappelijk artikel" @default.
- Q81561771 description "наукова стаття, опублікована в січні 2005" @default.
- Q81561771 name "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 name "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 type Item @default.
- Q81561771 label "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 label "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 prefLabel "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 prefLabel "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 P1433 Q81561771-9DA19BB4-DE87-45C6-9DCD-FCA849A81E6D @default.
- Q81561771 P1476 Q81561771-3D7AD786-EE9B-4805-95E1-02FB59C01709 @default.
- Q81561771 P2093 Q81561771-075FC73F-A636-4E2E-AF15-BD4C116CEF18 @default.
- Q81561771 P2093 Q81561771-50AECCC1-3D69-4A47-ACA4-3A3074E2C003 @default.
- Q81561771 P2093 Q81561771-64C3E456-B33E-40D8-93D4-BFFC830136DE @default.
- Q81561771 P2093 Q81561771-E1560CAB-A777-4896-8DF5-B9CC1990C9AC @default.
- Q81561771 P304 Q81561771-1D107EA7-0676-40EA-8B0D-49CD85D1767A @default.
- Q81561771 P31 Q81561771-CE0E20E5-FCCB-48F2-A6F4-787E636F8B34 @default.
- Q81561771 P356 Q81561771-5C40A1A5-C8EB-4D63-869F-8AD535D4B98A @default.
- Q81561771 P433 Q81561771-BAF73719-6417-43A6-ACB6-77C829CD600C @default.
- Q81561771 P478 Q81561771-32A5DEA8-93CA-462A-8D30-0FFBE3A8F838 @default.
- Q81561771 P577 Q81561771-CB04C745-2BB9-41AF-AE65-EACC7414E2F5 @default.
- Q81561771 P698 Q81561771-54D506BE-A876-4A31-8E17-1D02CC635784 @default.
- Q81561771 P356 J.EJCTS.2004.12.005 @default.
- Q81561771 P698 15784360 @default.
- Q81561771 P1433 Q2178577 @default.
- Q81561771 P1476 "The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation" @default.
- Q81561771 P2093 "Andreas Straub" @default.
- Q81561771 P2093 "Gerhard Ziemer" @default.
- Q81561771 P2093 "Hans Peter Wendel" @default.
- Q81561771 P2093 "Ruben Azevedo" @default.
- Q81561771 P304 "617-621" @default.
- Q81561771 P31 Q13442814 @default.
- Q81561771 P356 "10.1016/J.EJCTS.2004.12.005" @default.
- Q81561771 P433 "4" @default.
- Q81561771 P478 "27" @default.
- Q81561771 P577 "2005-01-13T00:00:00Z" @default.
- Q81561771 P698 "15784360" @default.